Results 201 to 210 of about 197,216 (310)

Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger. [PDF]

Int J Mol Sci
Cevenini A, De Antonellis P, Mazzarelli LL, Sarno L, D'Alessandro P, Pellicano M, Salomè S, Raimondi F, Guida M, Maruotti GM, Miceli M.   +10 more
europepmc   +1 more source

Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy

Asia-Pacific Journal of Clinical Oncology, EarlyView.
We report our single‐center experience of transplant outcomes with a busulfan, fludarabine and melphalan‐based conditioning regimen for children < 18 years of age. The regimen was shown to be well tolerated and effective for heavily pretreated children with high‐risk myeloid malignancies prior to allogeneic hematopoietic stem cell transplant.
Mayank Dhamija, Fiona Kerr, Hazel Gough, Johnathan Soggee, Laurence C. Cheung, Rishi S. Kotecha, Shanti Ramachandran   +6 more
wiley   +1 more source

Adoptive γδ T cell therapy controls cytomegalovirus infection in preclinical transplantation models. [PDF]

Nat Commun
Marsères G, Gentil C, Tinevez C, Courant M, Cosentino A, Cornillot-Clément S, Bigot V, Pitard V, Zouine A, Izotte J, Garrigue I, Prouzet-Mauleon V, Turcq B, Anglicheau D, Forcade E, Kaminski H, Silva-Santos B, Merville P, Capone M, Déchanet-Merville J, Couzi L.   +20 more
europepmc   +1 more source

Drug‐induced hypersensitivity syndrome followed by exacerbation of Crohn's disease

Pediatric Investigation, EarlyView.
Mei Kamidani, Ryo Tanaka, Hiroshi Oue, Risa Fukuda, Rena Hashimoto, Ichiro Takeuchi, Takako Yoshioka, Naoya Tonegawa, Akira Ishiguro, Katsuhiro Arai, Kazue Yoshida   +10 more
wiley   +1 more source

Update on Non‐Biological and RNA‐Based Therapeutics in Chronic Inflammatory Diseases: Precision Medicine Through Small Molecules: An EAACI Position Paper

Allergy, EarlyView.
ABSTRACT In the last decades, critical advancements in research technology and knowledge on disease mechanisms steered therapeutic approaches for chronic inflammatory diseases towards unprecedented target specificity. For allergic and chronic lung diseases, biologic drugs pioneered this goal, acquiring on the way—through the clinical use of monoclonal ...
F. Roth‐Walter, I. M. Adcock, C. Benito‐Villalvilla, R. Bianchini, L. Bjermer, G. Caramori, L. Cari, K. F. Chung, Z. Diamant, I. Eguiluz‐Gracia, E. F. Knol, M. Jesenak, F. Levi‐Schaffer, G. Nocentini, L. O'Mahony, O. Palomares, F. Redegeld, M. Sokolowska, B. Van Esch, M. Zurlo, C. Stellato   +20 more
wiley   +1 more source

Use of Maribavir in Adult Patients With Post-Transplant Refractory Cytomegalovirus Infection in the Real-Life Setting. [PDF]

Transpl Int
Kamar N, Vuotto F, Cordonnier C, Gatault P, Saliba F, Couzi L, Bunel V, Lefevre C, Maric M, Ziad A, Alain S.   +10 more
europepmc   +1 more source

Infection control in the brain and the eye

Acta Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source

Cytomegalovirus Infection Mimics Manifestations of Underlying Diseases in Patients With Autoimmune Disorders: A Case Report and Literature Review. [PDF]

Immun Inflamm Dis
Karimi E, Moradi Z, Soroureddin S, Nouri O, Tamartash Z, Kavosi H.   +5 more
europepmc   +1 more source